Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-l-Arabinofuranosyl)-5-Methylcytosine PET

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Nuclear Medicine

• Publication date

  2012-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2967/jnumed.111.090407PMID 22302964PMCID PMC3431619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of cancer cell metabolism

  2011cited by this paper
• Novel PET Probes Specific for Deoxycytidine Kinase

  2010influential reference
• Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

  2009cited by this paper
• Genetic factors influencing cytarabine therapy.

  2009cited by this paper
• Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography

  2009cited by this paper
• Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

  2009cited by this paper
• Clinical Applications of Metabolomics in Oncology: A Review

  2009cited by this paper
• Molecular imaging of lymphoid organs and immune activation using positron emission tomography with a new 18F-labeled 2′-deoxycytidine analog

  2008influential reference
• THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

  2007cited by this paper
• Review of recent studies on resistance to cytotoxic deoxynucleoside analogues.

  2007cited by this paper
• Discovery and development of clofarabine: a nucleoside analogue for treating cancer

  2006cited by this paper
• Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

  2006cited by this paper
• Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and Survival

  2006cited by this paper
• Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

  2005cited by this paper
• In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.

  2005influential reference
• Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line

  2004cited by this paper
• Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy†

  2003cited by this paper
• Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma

  2002cited by this paper
• Versatile retroviral vectors for potential use in gene therapy.

  1994cited by this paper
• Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.

  1973cited by this paper

• Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models.

  2024cites this paper
• In vivo clinical molecular imaging of T cell activity.

  2023cites this paper
• Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor

  2022cites this paper
• In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET

  2021cites this paper
• STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging

  2021cites this paper
• Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer.

  2021cites this paper
• Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia

  2019cites this paper
• Molecular Imaging

  2019cites this paper
• Defective Nucleotide Catabolism Defines a Subset of Cancers Sensitive to Purine Nucleoside Phosphorylase Inhibition

  2019cites this paper
• The 4-N-acyl and 4-N-alkyl gemcitabine analogues with silicon-fluoride-acceptor: Application to 18F-Radiolabeling.

  2018cites this paper
• 4-N-Alkanoyl and 4-N-alkyl gemcitabine analogues with NOTA chelators for 68-gallium labelling.

  2018cites this paper
• Gemcitabine analogues with 4-N-alkyl chain modified with fluoromethyl ketone group

  2018cites this paper
• Imaging Cancer Metabolism

  2017cites this paper
• In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models

  2017cites this paper
• OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 113 ( 17 ) ISSN 0027-8424

  2016cites this paper
• [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity

  2016cites this paper
• Advances in PET Detection of the Antitumor T Cell Response.

  2016cites this paper
• Synthetic routes to 18F-labelled gemcitabine and related 2’-fluoronucleosides

  2015cites this paper
• A novel radiochemical approach to 1-(2'-deoxy-2'-[(18) F]fluoro-β-d-arabinofuranosyl)cytosine ((18) F-FAC).

  2014cites this paper
• Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.

  2014cites this paper
• INDs for PET Molecular Imaging Probes—Approach by an Academic Institution

  2014cites this paper
• Synthesis and cytostatic evaluation of 4-N-alkanoyl and 4-N-alkyl gemcitabine analogues.

  2014cites this paper
• Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner

  2013cites this paper
• Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.

  2012cites this paper
• Chapter five--The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities.

  2012cites this paper